Navigation Links
OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
Date:10/13/2010

NEW YORK, Oct. 13 /PRNewswire/ -- OLIGOMERIX, Inc. announced today that Vic Micati, a Director since 2007, has been appointed Chairman of Oligomerix and that Jack Pasini has been appointed to the Company's Board of Directors and as Chief Commercial Officer.  

Having worked at Pfizer Inc. (PFE) for nearly 40 years, Mr. Micati was a member of Pfizer's Corporate Management Committee responsible for all aspects of global operations. He also served as Executive Vice President of the Pharmaceutical Group and Vice President of Pfizer Inc. He was appointed to the International Board of Directors in 1984 and became President of Pfizer's European operations in 1990.

Since 1999, Mr. Micati has worked as a consultant in the pharmaceutical industry and served on the board of several companies including Ilex Oncology (ILXO), subsequently acquired by Genzyme Corporation (GENZ), ENZON Pharmaceuticals Inc. (ENZN) and was member of the Advisory Board of Almirall, a Spanish pharmaceutical company.

Mr. Pasini is also a seasoned executive, having gained broad global commercial leadership experience during a 30-year career with Pfizer. Formerly, Mr. Pasini was Vice President, Worldwide Marketing responsible for Pfizer's Anti-Infective and Allergy/Respiratory Therapeutic Groups.  He also served as Vice President of Product Development, Regional President of the Africa, Middle East Region, and Vice President of Business Intelligence & Planning.  Mr. Pasini served on the board of the American Lung Association of the City of New York for five years.  Since his retirement in 2007, Mr. Pasini has worked as a consultant in the pharmaceutical industry.

"We are very pleased that Vic has agreed to take on the role of Chairman of Oligomerix and that Jack has agreed to join the Oligomerix Board and serve as Chief Commercial Officer.  We anticipate that Jack will play a key role in developing important partnerships within the industry to facilitate our transition into a full-scale biotechnology company," said James Moe, President & CEO.

ABOUT OLIGOMERIX

OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located within the Audubon Biomedical Science and Technology Park of Columbia University. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.  For more information visit www.oligomerix.com.Media Contact:Tiberend Strategic Advisors, Inc.212-827-0020Farrell Denbyfdenby@tiberendstrategicadvisors.com
'/>"/>

SOURCE OLIGOMERIX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy
2. Boston Scientific Announces Global Launch of Journey™ Guidewire
3. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
4. CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
5. Prime Therapeutics Announces URAC Accreditation
6. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
7. Cellectis bioresearch Announces Establishment of Subsidiary in the US
8. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
9. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
10. Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.
11. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... ... Establishment Labs, a global breast implant and medical technology company, is pleased ... , “We are honored to welcome David to our Board of Directors. ... Quiros, CEO of Establishment Labs. "David’s knowledge and experience will be invaluable to our ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has ... CEO of Freedom Laser Therapy , was determined to find solutions to his problems ... story of Inventors Digest is ready to introduce his breakthrough inventions to the ...
Breaking Medicine News(10 mins):